Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 35Carcinoma, Hepatocellular 28Stomach Neoplasms 12Neoplasm Metastasis 12Nasopharyngeal Carcinoma 11Neoplasms 10Esophageal Neoplasms 10Melanoma 8Esophageal Squamous Cell Carcinoma 8Colorectal Neoplasms 8Recurrence 7Lung Neoplasms 7Breast Neoplasms 7Biliary Tract Neoplasms 7Triple Negative Breast Neoplasms 6Small Cell Lung Carcinoma 5Rectal Neoplasms 5Pancreatic Neoplasms 5Head and Neck Neoplasms 5Cholangiocarcinoma 5Squamous Cell Carcinoma of Head and Neck 4Locally Advanced Rectal Cancer 4Colonic Neoplasms 4Carcinoma, Renal Cell 4Advanced NSCLC 4Urinary Bladder Neoplasms 3Sarcoma 3Liver Neoplasms 3Leukemia, Myeloid, Acute 3Hyperthermia 3

Interventions

Bevacizumab 17Capecitabine 13Cetuximab 10Oxaliplatin 8Irinotecan 8Fluorouracil 7Panitumumab 5Leucovorin 4trifluridine tipiracil drug combination 3sintilimab 3regorafenib 3Nivolumab 3Ipilimumab 3N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 2Folfox protocol 2Drug Therapy 2spartalizumab 1pembrolizumab 1irinotecan sucrosofate 1glucopyranosyl lipid-A 1folfirinox 1camrelizumab 1balstilimab 1anisodamine 1aflibercept 1XELOX 1Vemurafenib 1Tyrosine Kinase Inhibitors 1Transurethral Resection of Prostate 1Tomography, X-Ray Computed 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Colorectal Cancer Metastatic × Immune Checkpoint Inhibitors × Clear all
NCT07486492 2026-03-20

Using Healthy Gut Bacteria to Boost Immune Treatment for Advanced Bowel Cancer

The First Affiliated Hospital of Xiamen University

Phase EARLY_PHASE1 Not yet recruiting
10 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡